FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077828343> ?p ?o ?g. }

• W2077828343 endingPage "6706" @default.
• W2077828343 startingPage "6697" @default.
• W2077828343 abstract "GluA1 (formerly GluR1) AMPA receptor subunit phosphorylation at Ser-831 is an early biochemical marker for long-term potentiation and learning. This site is a substrate for Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) and protein kinase C (PKC). By directing PKC to GluA1, A-kinase anchoring protein 79 (AKAP79) facilitates Ser-831 phosphorylation and makes PKC a more potent regulator of GluA1 than CaMKII. PKC and CaM bind to residues 31–52 of AKAP79 in a competitive manner. Here, we demonstrate that common CaMKII inhibitors alter PKC and CaM interactions with AKAP79(31–52). Most notably, the classical CaMKII inhibitors KN-93 and KN-62 potently enhanced the association of CaM to AKAP79(31–52) in the absence (apoCaM) but not the presence of Ca2+. In contrast, apoCaM association to AKAP79(31–52) was unaffected by the control compound KN-92 or a mechanistically distinct CaMKII inhibitor (CaMKIINtide). In vitro studies demonstrated that KN-62 and KN-93, but not the other compounds, led to apoCaM-dependent displacement of PKC from AKAP79(31–52). In the absence of CaMKII activation, complementary cellular studies revealed that KN-62 and KN-93, but not KN-92 or CaMKIINtide, inhibited PKC-mediated phosphorylation of GluA1 in hippocampal neurons as well as AKAP79-dependent PKC-mediated augmentation of recombinant GluA1 currents. Buffering cellular CaM attenuated the ability of KN-62 and KN-93 to inhibit AKAP79-anchored PKC regulation of GluA1. Therefore, by favoring apoCaM binding to AKAP79, KN-62 and KN-93 derail the ability of AKAP79 to efficiently recruit PKC for regulation of GluA1. Thus, AKAP79 endows PKC with a pharmacological profile that overlaps with CaMKII. GluA1 (formerly GluR1) AMPA receptor subunit phosphorylation at Ser-831 is an early biochemical marker for long-term potentiation and learning. This site is a substrate for Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) and protein kinase C (PKC). By directing PKC to GluA1, A-kinase anchoring protein 79 (AKAP79) facilitates Ser-831 phosphorylation and makes PKC a more potent regulator of GluA1 than CaMKII. PKC and CaM bind to residues 31–52 of AKAP79 in a competitive manner. Here, we demonstrate that common CaMKII inhibitors alter PKC and CaM interactions with AKAP79(31–52). Most notably, the classical CaMKII inhibitors KN-93 and KN-62 potently enhanced the association of CaM to AKAP79(31–52) in the absence (apoCaM) but not the presence of Ca2+. In contrast, apoCaM association to AKAP79(31–52) was unaffected by the control compound KN-92 or a mechanistically distinct CaMKII inhibitor (CaMKIINtide). In vitro studies demonstrated that KN-62 and KN-93, but not the other compounds, led to apoCaM-dependent displacement of PKC from AKAP79(31–52). In the absence of CaMKII activation, complementary cellular studies revealed that KN-62 and KN-93, but not KN-92 or CaMKIINtide, inhibited PKC-mediated phosphorylation of GluA1 in hippocampal neurons as well as AKAP79-dependent PKC-mediated augmentation of recombinant GluA1 currents. Buffering cellular CaM attenuated the ability of KN-62 and KN-93 to inhibit AKAP79-anchored PKC regulation of GluA1. Therefore, by favoring apoCaM binding to AKAP79, KN-62 and KN-93 derail the ability of AKAP79 to efficiently recruit PKC for regulation of GluA1. Thus, AKAP79 endows PKC with a pharmacological profile that overlaps with CaMKII." @default.
• W2077828343 created "2016-06-24" @default.
• W2077828343 creator A5080499274 @default.
• W2077828343 creator A5087426501 @default.
• W2077828343 date "2011-02-01" @default.
• W2077828343 modified "2023-10-06" @default.
• W2077828343 title "Ca2+/Calmodulin-dependent Protein Kinase II Inhibitors Disrupt AKAP79-dependent PKC Signaling to GluA1 AMPA Receptors" @default.
• W2077828343 cites W1599213556 @default.
• W2077828343 cites W1609834322 @default.
• W2077828343 cites W1902132075 @default.
• W2077828343 cites W1964330366 @default.
• W2077828343 cites W1965167390 @default.
• W2077828343 cites W1968965593 @default.
• W2077828343 cites W1972719196 @default.
• W2077828343 cites W1976444641 @default.
• W2077828343 cites W1978155331 @default.
• W2077828343 cites W1980369656 @default.
• W2077828343 cites W1980656085 @default.
• W2077828343 cites W1982189649 @default.
• W2077828343 cites W1989961508 @default.
• W2077828343 cites W1993135690 @default.
• W2077828343 cites W1995792679 @default.
• W2077828343 cites W1999383552 @default.
• W2077828343 cites W2003853278 @default.
• W2077828343 cites W2005354573 @default.
• W2077828343 cites W2005766827 @default.
• W2077828343 cites W2009382649 @default.
• W2077828343 cites W2010920096 @default.
• W2077828343 cites W2011148606 @default.
• W2077828343 cites W2012974904 @default.
• W2077828343 cites W2016367251 @default.
• W2077828343 cites W2022512787 @default.
• W2077828343 cites W2024207015 @default.
• W2077828343 cites W2028450129 @default.
• W2077828343 cites W2030126027 @default.
• W2077828343 cites W2031104034 @default.
• W2077828343 cites W2031635859 @default.
• W2077828343 cites W2036869107 @default.
• W2077828343 cites W2039485121 @default.
• W2077828343 cites W2042774531 @default.
• W2077828343 cites W2049160574 @default.
• W2077828343 cites W2049970203 @default.
• W2077828343 cites W2050066016 @default.
• W2077828343 cites W2052322593 @default.
• W2077828343 cites W2062329658 @default.
• W2077828343 cites W2064374911 @default.
• W2077828343 cites W2067859370 @default.
• W2077828343 cites W2067883893 @default.
• W2077828343 cites W2068320316 @default.
• W2077828343 cites W2076018512 @default.
• W2077828343 cites W2077418346 @default.
• W2077828343 cites W2080120171 @default.
• W2077828343 cites W2082683998 @default.
• W2077828343 cites W2084343514 @default.
• W2077828343 cites W2085112484 @default.
• W2077828343 cites W2086737889 @default.
• W2077828343 cites W2089765713 @default.
• W2077828343 cites W2090865862 @default.
• W2077828343 cites W2090966488 @default.
• W2077828343 cites W2095484045 @default.
• W2077828343 cites W2099152777 @default.
• W2077828343 cites W2102170165 @default.
• W2077828343 cites W2103238833 @default.
• W2077828343 cites W2104933421 @default.
• W2077828343 cites W2105661186 @default.
• W2077828343 cites W2106389606 @default.
• W2077828343 cites W2106828113 @default.
• W2077828343 cites W2107117748 @default.
• W2077828343 cites W2109208582 @default.
• W2077828343 cites W2114121049 @default.
• W2077828343 cites W2116342741 @default.
• W2077828343 cites W2126920991 @default.
• W2077828343 cites W2128834282 @default.
• W2077828343 cites W2130907973 @default.
• W2077828343 cites W2133380824 @default.
• W2077828343 cites W2136736088 @default.
• W2077828343 cites W2138231889 @default.
• W2077828343 cites W2143650840 @default.
• W2077828343 cites W2150181109 @default.
• W2077828343 cites W2168319429 @default.
• W2077828343 cites W2168398034 @default.
• W2077828343 cites W2170532212 @default.
• W2077828343 cites W2170591768 @default.
• W2077828343 cites W2416051530 @default.
• W2077828343 cites W4247904703 @default.
• W2077828343 cites W565127267 @default.
• W2077828343 doi "https://doi.org/10.1074/jbc.m110.183558" @default.
• W2077828343 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3057809" @default.
• W2077828343 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21156788" @default.
• W2077828343 hasPublicationYear "2011" @default.
• W2077828343 type Work @default.
• W2077828343 sameAs 2077828343 @default.
• W2077828343 citedByCount "20" @default.
• W2077828343 countsByYear W20778283432012 @default.
• W2077828343 countsByYear W20778283432013 @default.
• W2077828343 countsByYear W20778283432014 @default.
• W2077828343 countsByYear W20778283432015 @default.
• W2077828343 countsByYear W20778283432016 @default.

• next